SREN 📈 Swiss Re - Overview
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0126881561
SREN: Reinsurance, Insurance, Risk Transfer, Property, Casualty, Life, Health
Swiss Re AG is a global provider of wholesale reinsurance, insurance, and other insurance-based forms of risk transfer, operating through a diverse range of segments to cater to various client needs. The company's business is divided into three primary segments: Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions, each designed to address specific aspects of risk management. The Property & Casualty Reinsurance segment is further specialized, offering a broad spectrum of reinsurance solutions including property, credit and surety, engineering, aviation, marine, agriculture, retakaful, and facultative reinsurance, as well as casualty reinsurance such as liability, motor, worker's compensation, personal accident, management and professional liability, cyber, and facultative reinsurance solutions.
The Life & Health Reinsurance segment focuses on underwriting life and health insurance products, providing clients with comprehensive coverage against various life and health-related risks. In contrast, the Corporate Solutions segment takes a more tailored approach, offering a range of risk transfer solutions from standard covers and multi-line programs to highly customized solutions designed to meet the unique needs of each client. Swiss Re AG serves a wide array of clients, including stock and mutual insurance companies, public sector and governmental entities, mid-sized and large corporations, and individuals, demonstrating its ability to adapt to different client profiles and risk management requirements.
With a history dating back to 1863, Swiss Re AG is one of the most established players in the reinsurance industry, boasting a rich legacy of providing risk management solutions to its clients worldwide. Headquartered in Zurich, Switzerland, the company is well-positioned to serve both global and regional markets, leveraging its extensive experience and expertise to navigate the complexities of the insurance and reinsurance landscape. For more information, clients and investors can visit the company's website at https://www.swissre.com, with the company's common stock listed under the ISIN CH0126881561 and classified under the GICS Sub Industry of Reinsurance.
Additional Sources for SREN Stock
SREN Stock Overview
Market Cap in USD | 42,719m |
Sector | Financial Services |
Industry | Insurance - Reinsurance |
GiC Sub-Industry | Reinsurance |
IPO / Inception |
SREN Stock Ratings
Growth 5y | 62.7% |
Fundamental | -12.8% |
Dividend | 52.3% |
Rel. Strength Industry | 49.2 |
Analysts | - |
Fair Price Momentum | 143.00 CHF |
Fair Price DCF | 364.01 CHF |
SREN Dividends
Dividend Yield 12m | 4.81% |
Yield on Cost 5y | 7.96% |
Annual Growth 5y | 0.43% |
Payout Consistency | 87.1% |
SREN Growth Ratios
Growth Correlation 3m | 77.5% |
Growth Correlation 12m | 89.3% |
Growth Correlation 5y | 86.5% |
CAGR 5y | 10.41% |
CAGR/Mean DD 5y | 0.78 |
Sharpe Ratio 12m | 1.55 |
Alpha | 20.00 |
Beta | 0.84 |
Volatility | 24.83% |
Current Volume | 2323.9k |
Average Volume 20d | 941.7k |
As of December 22, 2024, the stock is trading at CHF 128.50 with a total of 2,323,927 shares traded.
Over the past week, the price has changed by +1.02%, over one month by +3.07%, over three months by +11.44% and over the past year by +42.80%.
Neither. Based on ValueRay Fundamental Analyses, Swiss Re is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -12.83 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SREN as of December 2024 is 143.00. This means that SREN is currently undervalued and has a potential upside of +11.28% (Margin of Safety).
Swiss Re has no consensus analysts rating.
According to ValueRays Forecast Model, SREN Swiss Re will be worth about 154.6 in December 2025. The stock is currently trading at 128.50. This means that the stock has a potential upside of +20.3%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 135.1 | 5.2% |
Analysts Target Price | - | - |
ValueRay Target Price | 154.6 | 20.3% |